Macular Atrophy in the HARBOR Study for Neovascular Age-Related Macular Degeneration.

Sadda, SriniVas R; Tuomi, Lisa L; Ding, Beiying; Fung, Anne E; Hopkins, J Jill

Sadda, SriniVas R; Tuomi, Lisa L; Ding, Beiying; Fung, Anne E; Hopkins, J Jill.

Affiliation

Sadda SR; Doheny Eye Institute, Los Angeles, California; Department of Ophthalmology, Geffen School of Medicine, UCLA, Los Angeles, California. Electronic address: ssadda@doheny.org.
Tuomi LL; Genentech, Inc., South San Francisco, California.
Ding B; Genentech, Inc., South San Francisco, California.
Fung AE; Genentech, Inc., South San Francisco, California.
Hopkins JJ; Genentech, Inc., South San Francisco, California.

Ophthalmology ; 125(6): 878-886, 2018 06.

Article in En | MEDLINE | ID: mdl-29477692

Subject(s)

Angiogenesis Inhibitors/therapeutic use; Choroidal Neovascularization/drug therapy; Geographic Atrophy/diagnosis; Ranibizumab/therapeutic use; Wet Macular Degeneration/drug therapy; Aged; Aged, 80 and over; Choroidal Neovascularization/diagnosis; Choroidal Neovascularization/physiopathology; Double-Blind Method; Female; Fluorescein Angiography; Geographic Atrophy/physiopathology; Humans; Incidence; Intravitreal Injections; Male; Prospective Studies; Retrospective Studies; Subretinal Fluid; Tomography, Optical Coherence; Vascular Endothelial Growth Factor A/antagonists & inhibitors; Visual Acuity/physiology; Wet Macular Degeneration/diagnosis; Wet Macular Degeneration/physiopathology

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Choroidal Neovascularization / Angiogenesis Inhibitors / Geographic Atrophy / Wet Macular Degeneration / Ranibizumab Type of study: Diagnostic_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Aged80 / Female / Humans / Male Language: En Journal: Ophthalmology Year: 2018 Type: Article

Fulltext

XML

PubMed Links

Search on Google